We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+14.38%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$328M
AUM Growth
-$148M
Cap. Flow
-$221M
Cap. Flow %
-67.45%
Top 10 Hldgs %
63.05%
Holding
69
New
17
Increased
10
Reduced
14
Closed
18

Top Buys

Rank Stock Value
1
CYBE
Cyberoptics Corp
CYBE
+$16M
2
MRAM icon
Everspin Technologies
MRAM
+$14.1M
3
SCYX icon
SCYNEXIS
SCYX
+$11M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.26M
5
LTRX icon
Lantronix
LTRX
+$5.22M

Top Sells

Rank Stock Value
1
SIMO icon
Silicon Motion
SIMO
+$83.2M
2
EMKR
Emcore Corp
EMKR
+$22.7M
3
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$16.5M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$12.7M
5
OIIM
02Micro International
OIIM
+$8.99M

Sector Composition

Rank Sector Weight
1 Technology 55.75%
2 Healthcare 28.63%
3 Industrials 1.21%
4 Consumer Staples 0.51%
5 Financials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKTI icon
26
BK Technologies
BKTI
$293M
$3.23M 0.98%
268,000
– –
RNAZ icon
27
TransCode Therapeutics
RNAZ
$4.36M
$3.23M 0.98%
2
– –
NBSE
28
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2.81M 0.86%
+50,014
New +$3.36M
ARDX icon
29
Ardelyx
ARDX
$1.22B
$2.64M 0.81%
+2,401,807
New +$2.85M
ALIM
30
DELISTED
Alimera Sciences
ALIM
$2.55M 0.78%
497,639
-3,386
-0.7% -$16.6K
PDSB icon
31
PDS Biotechnology
PDSB
$41.1M
$2.5M 0.76%
308,034
-465,526
-60% -$5.01M
IPWR icon
32
Ideal Power
IPWR
$71.1M
$2.41M 0.73%
199,732
+55,385
+38% +$741K
ALNA
33
DELISTED
Allena Pharmaceuticals
ALNA
$2.37M 0.72%
4,000,000
– –
EMKR
34
DELISTED
Emcore Corp
EMKR
$2.05M 0.62%
29,335
-307,680
-91% -$22.7M
CNTX icon
35
Context Therapeutics
CNTX
$46.1M
$2.03M 0.62%
+762,721
New +$3.8M
BLIN icon
36
Bridgeline Digital
BLIN
$14M
$1.98M 0.6%
877,193
-382,451
-30% -$1.21M
FKWL icon
37
Franklin Wireless
FKWL
$26.5M
$1.7M 0.52%
390,000
-390,000
-50% -$1.82M
YTEN
38
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$1.68M 0.51%
14,250
– –
BWAY
39
Brainsway
BWAY
$627M
$1.6M 0.49%
415,694
-464,908
-53% -$1.85M
PCSA icon
40
Processa Pharmaceuticals
PCSA
$6.45M
$1.49M 0.45%
607
-167
-22% -$517K
HSDT icon
41
Solana Company
HSDT
$98.1M
$1.3M 0.4%
+7
New +$2.49M
RZLT icon
42
Rezolute
RZLT
$450M
$1.27M 0.39%
+265,181
New +$1.55M
CYTHW
43
CALL
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$1.1M 0.34%
+294,931
New +$711K
NMTC icon
44
NeuroOne Medical Technologies
NMTC
$13.5M
$921K 0.28%
+79,167
New +$1.28M
NLSPW
45
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$919K 0.28%
827,921
– –
CLRB icon
46
Cellectar Biosciences
CLRB
$20.1M
$596K 0.18%
+2,989
New +$720K
ABEO icon
47
Abeona Therapeutics
ABEO
$395M
$383K 0.12%
+45,491
New +$836K
PETVW
48
CALL
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$377K 0.11%
+100,000
New +$65K
DRMAW icon
49
CALL
Dermata Therapeutics Warrant
DRMAW
$14.1K
$305K 0.09%
+175,000
New +$138K
CGTX icon
50
Cognition Therapeutics
CGTX
$102M
$161K 0.05%
+25,496
New +$249K
1
2
3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $738M AUM 32.56% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return

AIGH Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, AIGH Capital Management held 69 positions worth $328M, down 31% from $476M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

AIGH Capital Management withdrew a net $221M in Q4 2021, closing 18 positions and reducing 14 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIGH Capital Management opened a new position in Everspin Technologies worth $17.6M.

  • AIGH Capital Management's largest Q4 2021 buy was Everspin Technologies: 1,555,026 shares worth $17.6M.
  • AIGH Capital Management added most to Cyberoptics Corp in Q4 2021, an estimated $16M increase.
  • AIGH Capital Management's biggest Q4 2021 reduction was Silicon Motion, cutting an estimated $83.2M.
  • AIGH Capital Management fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $16.5M.
  • AIGH Capital Management's ten largest holdings make up 63% of its $328M portfolio in Q4 2021.
  • AIGH Capital Management opened 17 new positions and closed 18 in Q4 2021.
  • AIGH Capital Management's portfolio value fell 31% quarter-over-quarter to $328M.

Based on AIGH Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.